SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002745
Filing Date
2024-01-08
Accepted
2024-01-08 09:12:01
Documents
12
Period of Report
2024-01-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20240108.htm   iXBRL 8-K 39512
  Complete submission text file 0000950170-24-002745.txt   160972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20240108.xsd EX-101.SCH 2493
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20240108_lab.xml EX-101.LAB 13896
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20240108_pre.xml EX-101.PRE 10246
6 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20240108_htm.xml XML 4885
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 24518623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)